{
  "id": "everyday#screening_cues_bb171e70",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "7. Important social, occupational, or recreational activities are given up or reduced because of phencyclidine use. 8. Recurrent phencyclidine use in situations in which it is phys- ically hazardous (e.g., driving an automobile or operating a machine when impaired by a phencyclidine). 9. Phencyclidine use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the phencyclidine. 10. Tolerance, as defined by either of the following: a. A need for markedly increased amounts of the phency- clidine to achieve intoxication or desired effect. b. A markedly diminished effect with continued use of the same amount of the phencyclidine. Note: Withdrawal symptoms and signs are not established for phencyclidines, and so this criterion does not apply. (Withdrawal from phencyclidines has been reported in animals but not docu- mented in human users.) Specify if: In early remission: After full criteria for phencyclidine use disor- der were previously met, none of the criteria for phencyclidine use disorder have been met for at least 3 months but for less than 12 months (with the exception that Criterion A4, “Craving, or a strong desire or urge to use the phencyclidine,” may be met). In sustained remission: After full criteria for phencyclidine use dis- order were previously met, none of the criteria for phencyclidine use disorder have been met at any time during a period of 12 months or longer (with the exception that Criterion A4, “Craving, or a strong desire or urge to use the phencyclidine,” may be met).",
  "gloss_vi": "7. important social, occupational, or recreational activities are given up or reduced because of phencyclidine use.",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues"
    ],
    "life_topics": [],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc 7. Important social, occupational, or recreational activities are given up or reduced because of phencyclidine use. 8. Recurrent phencyclidine use in situations in which it is phys- ically hazardous (e.g., driving an automobile or operating a machine when impaired by a phencyclidine). 9. Phencyclidine use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the phencyclidine. 10. Tolerance, as defined by either of the following: a. A need for markedly increased amounts of the phency- clidine to achieve intoxication or desired effect. b. A markedly diminished effect with continued use of the same amount of the phencyclidine. Note: Withdrawal symptoms and signs are not established for phencyclidines, and so this criterion does not apply. (Withdrawal from phencyclidines has been reported in animals but not docu- mented in human users.) Specify if: In early remission: After full criteria for phencyclidine use disor- der were previously met, none of the criteria for phencyclidine use disorder have been met for at least 3 months but for less than 12 months (with the exception that Criterion A4, “Craving, or a strong desire or urge to use the phencyclidine,” may be met). In sustained remission: After full criteria for phencyclidine use dis- order were previously met, none of the criteria for phencyclidine use disorder have been met at any time during a period of 12 months or longer (with the exception that Criterion A4, “Craving, or a strong desire or urge to use the phencyclidine,” may be met). 7. important social, occupational, or recreational activities are given up or reduced because of phencyclidine use."
}